comparemela.com

Latest Breaking News On - Adma biologics inc - Page 3 : comparemela.com

ADMA Biologics, Inc. (NASDAQ:ADMA) Sees Large Decrease in Short Interest

ADMA Biologics, Inc. (NASDAQ:ADMA) Sees Large Decrease in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
York-mellon-corp
Bailard-inc
Cantor-fitzgerald
Biologics-inc
Alberta-investment-management-corp
Adma-biologics-inc
Nasdaq
Get-free-report
Wealth-advisors
New-york-mellon-corp

ADMA Biologics (ADMA) Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update

ADMA Biologics (ADMA) Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Adam-grossman
Nasdaq
Adma-biologics-inc
Drug-administration
Chief-executive-officer
Growth-opportunities
Production-yield-enhancement
Pipeline-introduction
Hyperimmune-globulin
United-states-food
Adverse-reactions

Should You Buy Adma Biologics (ADMA) After Golden Cross?

ADMA Biologics (ADMA) Announces FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD

ADMA Biologics (ADMA) Announces FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Maryland
United-states
Adam-grossman
Brian-lenz
Nasdaq
Adma-biologics-inc
Drug-administration
License-application
Chief-executive-officer
Executive-vice-president
Chief-financial-officer
General-manager

FY2024 EPS Estimates for ADMA Biologics, Inc. Boosted by Analyst (NASDAQ:ADMA)

ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) – Cantor Fitzgerald raised their FY2024 EPS estimates for shares of ADMA Biologics in a note issued to investors on Thursday, November 9th. Cantor Fitzgerald analyst K. Kluska now forecasts that the biotechnology company will post earnings per share of $0.18 for the year, up from their previous […]

United-states
Mizuho
Sakhalinskaya-oblast
Russia
Adams-grossman
Raymond-james
Brian-lenz
Cantor-fitzgerald
Allspring-global-investments-holdings
Adma-biologics-inc
Bailard-inc
Nasdaq

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.